Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its Gene...
Q1 2026
Apr 28, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 7, 2025